Qiagen N.V.
Qiagen N.V. (QGEN) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · QGEN · as of Mar 31, 2025
Ownership Breakdown
303
Institutional Holders
▼ 34 vs Q4
$5.89B
Total Inst. Value
▼ $695.98M vs Q4
206.25M
Shares Outstanding
freeFloat 99.29%
162.92M
13F Shares Held
▼ 15.99M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
QGEN largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ biological products, (no diagnostic substances) | 25.30M | 11.01% | 11.01% | $1.02T | May 2, 2025 | NEW |
WELLINGTON MANAGEMENT GROUP LLP biological products, (no diagnostic substances) | 24.44M | 10.63% | 10.63% | $972.19B | May 13, 2025 | NEW |
GROUPAMA ASSET MANAGMENT biological products, (no diagnostic substances) | 16.00M | 6.96% | 6.96% | $15.90B | May 14, 2025 | NEW |
VANGUARD GROUP INC biological products, (no diagnostic substances) | 8.88M | 3.86% | 3.86% | $352.76B | May 9, 2025 | NEW |
BLACKROCK, INC. biological products, (no diagnostic substances) | 5.47M | 2.38% | 2.38% | $219.49B | May 2, 2025 | NEW |
DEUTSCHE BANK AG\ biological products, (no diagnostic substances) | 4.49M | 1.95% | 1.95% | $180.32B | May 9, 2025 | NEW |
PRICE T ROWE ASSOCIATES INC /MD/ biological products, (no diagnostic substances) | 4.47M | 1.94% | 1.94% | $179.50B | May 14, 2025 | ▲ 4.33M |
AMUNDI biological products, (no diagnostic substances) | 4.35M | 1.89% | 1.89% | $175.76B | May 15, 2025 | NEW |
EARNEST PARTNERS LLC biological products, (no diagnostic substances) | 3.81M | 1.66% | 1.66% | $152.84B | May 14, 2025 | NEW |
BANK OF AMERICA CORP /DE/ biological products, (no diagnostic substances) | 3.39M | 1.47% | 1.47% | $136.02B | May 15, 2025 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
1
Increased
+4.33M shares48
New Positions
first time holders1
Decreased
−321.1K shares0
Sold Out
fully exitedNet shares change (top 50)
+4.01M
+4.33M / −321.1K
Net new holders
+48
48 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
QGEN insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Qiagen N.V. (QGEN) is primarily owned by institutional investors, who hold approximately 79.0% of total shares outstanding. Company insiders own approximately 0.71%, while retail and public investors account for the remaining 20.30%.
The largest institutional shareholder of Qiagen N.V. is MASSACHUSETTS FINANCIAL SERVICES CO /MA/, holding approximately 25.30 million shares — equal to 11.01% of outstanding shares — as of March 31, 2025.
A total of 303 institutional investors currently hold QGEN stock, with a combined institutional value of approximately $5.89 billion as of the most recent 13F filing period.
Frequently asked questions
QGEN ownershipQiagen N.V. (QGEN) is primarily owned by institutional investors, who hold approximately 79.0% of shares. The largest shareholder is MASSACHUSETTS FINANCIAL SERVICES CO /MA/ with a 11.01% stake. Company insiders hold 0.71%. Data sourced from SEC Form 13F as of March 31, 2025.